Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

Abstract

BACKGROUND & AIMS:

Barrett's esophagus (BE) can progress to dysplasia and esophageal adenocarcinoma (EAC), accompanied by mutations in TP53 that increase the stability of its product, p53. We analyzed BE tissues for messenger RNAs (mRNAs) that associate with BE progression and identified one that affects the stabilization of p53.

METHODS:

We obtained 54 BE samples collected from patients with high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC), from 1992 through 2015, and performed RNA sequence analyses, including isoform-specific analyses. We performed reverse-transcription polymerase chain reaction analyses of 166 samples and immunohistochemical analyses of tissue microarrays that contained BE tissues from 100 patients with HGD or EAC and normal esophageal squamous mucosa (controls). Proteins were expressed from transfected plasmids or knocked down with small interfering RNAs in BE cells and analyzed by immunoblots and in immunoprecipitation and ubiquitin ligase assays. Athymic nude mice bearing EAC xenograft tumors (grown from OE-33 cells) were given intraperitoneal injections of simvastatin; tumor growth was monitored and tumors were collected and analyzed by immunoblotting for levels of RNF128, p53, and acetylated p53.

RESULTS:

Progression of BE to HGD or EAC associated with changes in expression of mRNAs that encoded mucins and promoted inflammation and activation of ATM and the DNA damage response. As tissues progressed from BE to HGD to EAC, they increased expression of mRNAs encoding isoform 1 of RNF128 (Iso1) and decreased expression of Iso2 of RNF128. RNF128 is an E3 ubiquitin ligase that targets p53 for degradation. Incubation of BE cells with interferon gamma caused them to increase expression of Iso1 and reduce expression of Iso2. Iso1 was heavily glycosylated with limited ubiquitin ligase activity for p53, resulting in p53 stabilization. Knockdown of Iso1 in BE and EAC cells led to degradation of the mutant form of p53 and reduced clonogenic survival. In contrast, Iso2 was a potent ligase that reduced levels of the mutant form of p53 in BE cells. In BE cells, Iso2 was hypoglycosylated and degraded, via ATM and GSK3β-mediated phosphorylation and activation of the beta-TrCP1-containing SCF ubiquitin ligase complex. Simvastatin, which degrades the mutant form of p53, also degraded RNF128 Iso1 protein in BE cells and slowed growth of EAC xenograft tumors in mice.

CONCLUSIONS:

We found that isoform 2 of RNF128 is decreased in BE cells, resulting in increased levels of mutant p53, whereas isoform 1 of RNF128 is increased in BE cells, further promoting the stabilization of mutant p53.

• Authors: Dipankar Ray, Paramita Ray, Daysha Ferrer-Torres, Zhuwen Wang, Derek Nancarrow, Hee-Won Yoon, May San Martinho, Tonaye Hinton, Scott Owens, Dafydd Thomas, Hui Jiang, Theodore S Lawrence, Jules Lin, Kiran Lagisetty, Andrew C Chang, David G Beer
• Journal: Gastroenterology (Gastroenterology) Vol. 158 Issue 3 Pg. 583-597.e1 (02 2020) ISSN: 1528-0012 [Electronic] United States
• PMID: 31715145 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Chemical References

• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Isoenzymes
• RNA, Messenger
• Tumor Suppressor Protein p53
• Interferon-gamma
• Simvastatin
• RNF128 protein, human
• Ubiquitin-Protein Ligases

Topics

• Adenocarcinoma (genetics, metabolism, pathology)
• Animals
• Barrett Esophagus (genetics, metabolism, pathology)
• Cells, Cultured
• Down-Regulation (drug effects)
• Esophageal Neoplasms (genetics, metabolism, pathology)
• Esophagus (metabolism)
• Female
• Gene Expression (drug effects)
• Gene Silencing
• Glycosylation
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (pharmacology)
• Interferon-gamma (pharmacology)
• Isoenzymes (genetics, metabolism)
• Mice
• Mice, Nude
• Neoplasm Transplantation
• RNA, Messenger (metabolism)
• Signal Transduction
• Simvastatin (pharmacology)
• Tumor Suppressor Protein p53 (genetics, metabolism)
• Ubiquitin-Protein Ligases (genetics, metabolism)